Skip to Main Content

Paper Details

Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1.
J Clin Invest
42
2018
Author NameAffiliation
Vivek NaranbhaiRagon Institute of MGH
Vivek NaranbhaiUniversity of KwaZulu-Natal
Ying QiLeidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research
Xiaojiang GaoLeidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research
Jonathan M Carlson
Steven M WolinskyNorthwestern University Feinberg School of Medicine
Bruce D WalkerRagon Institute of MGH
Bruce D WalkerRagon Institute of MGH
Steven G DeeksSan Francisco General Hospital Medical Center
Steven G DeeksSan Francisco General Hospital Medical Center
David W HaasVanderbilt University School of Medicine
David W HaasVanderbilt University School of Medicine
Stephen A MiguelesNational Institute of Allergy and Infectious Diseases (NIAID)
Mark ConnorsNational Institute of Allergy and Infectious Diseases (NIAID)
Jacques FellaySwiss Federal Institute of Technology
Mary CarringtonLeidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research
Mary CarringtonRagon Institute of MGH
Mary CarringtonLeidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research
Mary CarringtonRagon Institute of MGH
  • 1 - 19

Datasets